TCL Archive Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says April 26, 1996
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Obey Surprises Everyone, Including Himself, And Plugs For More Money For NCI, NHLBI March 7, 1980
TCL Archive Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991 November 9, 1990
TCL Archive White House Proposes NCI Budget Cut Of $40 Million or FY2007; NIH Budget Flat. Cuts And Earmarks Threaten To Derail 2015 Goal, NCI Director Says; “We Are In Difficult Times.” February 10, 2006